Blood Brain Barrier Relaxers as a Differentiated Approach to Systemic CNS Delivery of Oligonucleotides
- Overview of the underlying technology and its mechanism of action
- Presentation of key in vivo data demonstrating enhanced CNS delivery
- Comparison of this approach with existing CNS oligonucleotide delivery strategies